From "The Intelligent Investor Third Edition"
🎧 Listen to Summary
Free 10-min PreviewEvaluating Company Performance Across Six Dimensions
Key Insight
Effective investment requires shifting focus from superficial stock prices to fundamental business performance, analyzed through six dimensions: profitability, stability, growth, financial position, dividends, and price history. Contemporary examples illustrate this: Emerson Electric, an engineering giant with over $15 billion in annual revenue and a $54 billion market value (2024), has been profitable from 1993 to 2022 and increased its dividend every year since 1956. However, its earnings per share from continuing operations grew by only 8% cumulatively over five years to 2023, barely surpassing its 2015 level, and its stock underperformed the S&P 500 by 5.7 percentage points annually over the decade ending 2023.
Other companies demonstrate varied outcomes across these dimensions. Energizer Holdings exhibited erratic profitability, with earnings ranging from $201 million in 2017 to a $231 million loss in 2022, and its stock gained an average of only 2% annually since 2015. Eastman Kodak, a former industry leader, saw its annual revenues shrink by 93% between 1993 and 2022, incurred $3.3 billion in losses over two decades, has not paid a dividend since 2003, and its shares fell over 88% over the decade to 2023. Exact Sciences, conversely, transformed from nearly being delisted with minimal sales to generating $2.5 billion in annual revenues by 2023, enduring over $3.1 billion in cumulative losses while pursuing long-term growth, with its stock returning over 20% annually over ten years, albeit with significant volatility.
None of these contemporary companies passed the stability test of no earnings decline against the prior three years' average over ten years, with Kodak and Exact Sciences faring the worst. Financial positions also vary widely: Emerson's $16 billion debt appears manageable against $43 billion in total assets, while Energizer's $3.3 billion long-term debt is substantial relative to its $211 million shareholders' equity. Exact Sciences has over $2.3 billion in convertible notes, implying future share dilution. Evaluating companies via these six dimensions allows investors to look beyond temporary stock surges and market momentum, which can be illusory, enabling a better assessment of a business's lifecycle phase and its potential for distinction or extinction.
📚 Continue Your Learning Journey — No Payment Required
Access the complete The Intelligent Investor Third Edition summary with audio narration, key takeaways, and actionable insights from Benjamin Graham, Jason Zweig.